Kura Oncology chief commercial officer Brian T. Powl sells $3,256.96 in common shares
KURA•Kura Oncology Chief Commercial Officer Brian T. Powl sold 448 common shares at $7.27 each on November 19, 2026. His direct holdings totaled 112,817 common shares after the sale.




